BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21565947)

  • 21. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome.
    Feinberg MS; Schwartz R; Tanne D; Fisman EZ; Hod H; Zahger D; Schwammethal E; Eldar M; Behar S; Tenenbaum A
    Am J Cardiol; 2007 Mar; 99(5):667-72. PubMed ID: 17317369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Framingham risk score despite high prevalence of metabolic syndrome in asymptomatic North-Indian population.
    Bansal M; Shrivastava S; Mehrotra R; Agarwal V; Kasliwal RR
    J Assoc Physicians India; 2009 Jan; 57():17-22. PubMed ID: 19753753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study.
    Girman CJ; Dekker JM; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Am J Epidemiol; 2005 Sep; 162(5):438-47. PubMed ID: 16076828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B; Voigt W; Nobel W; Janka HU
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification.
    Johnson DW; Armstrong K; Campbell SB; Mudge DW; Hawley CM; Coombes JS; Prins JB; Isbel NM
    Nephrology (Carlton); 2007 Aug; 12(4):391-8. PubMed ID: 17635756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.
    Sánchez-Gómez JM; Martínez-Dolz L; Sánchez-Lázaro I; Almenar L; Sánchez-Lacuesta E; Muñoz-Giner B; Portolés M; Rivera M; Valera-Román A; González-Juanatey JR; Tejada-Ponce D; Agüero J; Buendía F; Salvador A
    Transplantation; 2012 Jan; 93(1):106-11. PubMed ID: 22134367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome does not increase angiographic restenosis rates after drug-eluting stent implantation.
    Canibus P; Faloia E; Piva T; Muçai A; Serenelli M; Perna GP; Boscaro M; Piva R
    Metabolism; 2008 May; 57(5):593-7. PubMed ID: 18442619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre.
    Fang W; Qian J; Lin A; Rowaie F; Ni Z; Yao Q; Bargman JM; Oreopoulos DG
    Nephrol Dial Transplant; 2008 Dec; 23(12):4021-8. PubMed ID: 18790809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre.
    Chung SH; Heimbürger O; Lindholm B; Lee HB
    Nephrol Dial Transplant; 2005 Jun; 20(6):1207-13. PubMed ID: 15784640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
    Leoncini G; Ratto E; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Hum Hypertens; 2007 Oct; 21(10):802-7. PubMed ID: 17541383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular prognosis at 1-year of patients with acute coronary syndrome is related to abdominal aortic aneurysm despite small size of the aneurysm.
    Bui HT; Barbe C; Nazeyrollas P; Metz D; Long A
    Ann Vasc Surg; 2011 Oct; 25(7):913-9. PubMed ID: 21620652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
    Marotta T; Russo BF; Ferrara LA
    Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early initiation of peritoneal dialysis in diabetic patients.
    Coronel F; Cigarran S; Herrero JA
    Scand J Urol Nephrol; 2009; 43(2):148-53. PubMed ID: 19085460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.